for the fi rst time, the annual scientific meeting of the … · 2019. 5. 13. · ©overcome may...
TRANSCRIPT
©ov
erco
me
MAY 8-92020
For the fi rst time, the ANNUAL SCIENTIFIC MEETING OF THE INTERNATIONAL SOCIETY OF CARDIOVASCULARPHARMACOTHERAPY (ISCP) will come to the US for its 25TH congress!
w w w . i s c p 2 0 2 0 . c o m
ISCP 2020 PRELIMINARY PROGAMME TOPICS
Acute Coronary Syndromes
• STEMI Culprit Lesion vs Complete revascularization• Stents Bioreabsorbable Scaffl ods• Post PCI anticoagulants. • Acute ischemic stroke. Novel approaches
The Challenges of controlling blood
pressure
• Non-Pharmacologic treatment. How much salt?
• Personalize blood pressure target. Digital medicine
• Obesity and hypertension. The dual threat
New Concepts on Atrial Fibrillation
• Pharmacologic treatment (Who, How, When)• The role of Anticoagulation in atrial fibrillation
Prevention of Cardiovascular
Disease
• Atherosclerosis and lipid management• Diet and prevention of atherosclerosis• Meet the experts:
1) Management of heart failure: Role of sacubitril valsartan
2) Anticoagulation in atrial fibrillation: when and how3) Resistant hypertension: diagnosis and management4) Digital Monitoring in hypertension5) Sleep apnea management
Pulmonary Hypertension
• Diagnosis and the role of RHC• Management Pharmacological or SurgicalThe dual threat
Heart Failure with Preserved EF
• Non-Pharmacologic management of HFpEF• Therapies for HFpEF
Point/Counterpoint• Management of HFmEF
1) HFmEF should be treated as HFrEF2) HFmEF should be treated as HFpEF
Panel Discussion Lipid therapy or Anti-
infl ammatory therapy for atherosclerosis
• Lipid targets: HDL effl ux capacity• PCSK9- inhibitors (when)• Infl ation and atherosclerosis a new target
Henry N. Neufeld Memorial Award Lecture • Precision Medicine
Cardiomyopathy update
• Utilization of Biomarkers in Heart Failure• Management Approach to Myocarditis • Amyloid and new therapies
Lecture • Hypertrophic Cardiomyopathy: Epidemiology and Management (B Maron)
Heart failure update• Guideline therapy for heart failure in clinical practice• Present and future therapies for heart failure • Targeting myocardial fi brosis in HFpEF
Peripheral Arterial and venous Disease
• Management of PAD • Management of Deep Venous Thrombosis • Diagnosis and Management of Pulmonary Thromboembolic disease
For registration and abstract presentation, plase consult our website: www.iscp2020.com
For further information, please contact: Kim Ly, Project Manager - [email protected] - Tel: +33 (0)1 40 88 97 97Overcome: Offi cial PCO for ISCP 2020 - 13-15 rue des Sablons, 75116 PARIS - France